Insmed
INSM
#1079
Rank
โ‚ฌ19.33 B
Marketcap
88,54ย โ‚ฌ
Share price
-1.75%
Change (1 day)
-37.34%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -โ‚ฌ0.68 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚ฌ1.13 Billion. In 2025 the company made an earning of -โ‚ฌ1.07 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.68 Billion-36.69%
2025 -โ‚ฌ1.07 Billion43.91%
2024 -โ‚ฌ0.75 Billion23.71%
2023 -โ‚ฌ0.61 Billion45.77%
2022 -โ‚ฌ0.42 Billion15.83%
2021 -โ‚ฌ0.36 Billion50.19%
2020 -โ‚ฌ0.24 Billion16.4%
2019 -โ‚ฌ0.21 Billion-23.9%
2018 -โ‚ฌ0.27 Billion59.35%
2017 -โ‚ฌ0.17 Billion8.52%
2016 -โ‚ฌ0.16 Billion47.25%
2015 -โ‚ฌ0.11 Billion34.53%
2014 -โ‚ฌ78.09 Million58.83%
2013 -โ‚ฌ49.17 Million35.14%
2012 -โ‚ฌ36.38 Million-31.92%
2011 -โ‚ฌ53.44 Million854.92%
2010 -โ‚ฌ5.6 Million-105.22%
2009 โ‚ฌ0.10 B-905.06%
2008 -โ‚ฌ13.31 Million-27.31%
2007 -โ‚ฌ18.31 Million-62.41%
2006 -โ‚ฌ48.71 Million98.19%
2005 -โ‚ฌ24.58 Million0.03%
2004 -โ‚ฌ24.57 Million159.07%
2003 -โ‚ฌ9.49 Million-69.31%
2002 -โ‚ฌ30.9 Million
2000 -โ‚ฌ27.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ13.90 B-2,056.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-โ‚ฌ1.76 Billion 146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ4.51 B-735.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚ฌ0.12 Billion-83.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ20.82 Million-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚ฌ46.27 Million-93.49%๐Ÿ‡บ๐Ÿ‡ธ USA